Comprehensive review examines nano-adjuvant technologies for poultry vaccines globally

This comprehensive review evaluates the application of nano-adjuvant technologies in poultry vaccination strategies. The scope includes lipid nanoparticles, polymeric systems, virosomes, mesoporous silica, polysaccharides, nanoemulsions, Toll-like receptor agonist-loaded nano-adjuvants, and virus-like particles. These are compared against existing vaccines such as live-attenuated, inactivated, and subunit formulations. The setting is described as global, though the sample size was not reported. The review does not report a specific primary outcome or follow-up duration.

The authors synthesize arguments indicating that nano-adjuvants may provide enhanced vaccine immunogenicity, enhanced stability, and targeted delivery. Secondary outcomes discussed include robust humoral and cellular immune responses, Th1/Th2 balance, dose-sparing strategies, amplified dendritic cell activation, enhanced antigen presentation, durable memory responses, and broad, long-lasting protection against very virulent and emerging IBDV variants. The review highlights the potential for safer, more effective, and globally deployable strategies to safeguard poultry health and productivity.

Limitations acknowledged by the authors include the absence of reported adverse events, serious adverse events, discontinuations, or tolerability data. The review does not provide specific numerical data or p-values. Consequently, the practice relevance is framed cautiously, offering potential strategies rather than definitive clinical recommendations based on trial data. The review serves as a qualitative synthesis of current technological possibilities in this field.